699851P

3A-MPLA

Avanti Research^™ - A Croda Brand 699851P, powder

• Sinônimo(s): Monophosphoryl Tri-acyl Lipid A (Synthetic)
• Fórmula empírica (Notação de Hill): C₅₄H₁₀₆N₃O₁₇P
• Número CAS: 1699735-80-2
• Peso molecular: 1100.40
• Código UNSPSC: 12352211
• NACRES: NA.25

Propriedades

• Ensaio: >99% (HPLC)
• forma: powder
• embalagem: pkg of 1 × 1 mg (699851P-1mg); pkg of 1 × 5 mg (699851P-5mg)
• fabricante/nome comercial: Avanti Research^™ - A Croda Brand 699851P
• aplicação(ões): vaccine development
• Condições de expedição: dry ice
• temperatura de armazenamento: −20°C
• cadeia de caracteres SMILES: O[C@H]([C@@H](CO[C@@H]([C@@H]1NC(C[C@H](OC(CCCCCCCCCCCCC)=O)CCCCCCCCCCC)=O)O[C@H](CO)[C@@H](OP([O-])(O)=O)[C@@H]1O)O[C@H](O)[C@@H]2NC(C[C@H](O)CCCCCCCCCCC)=O)[C@@H]2O.[NH4+]

Descrição

Descrição geral

Monophosphoryl lipid A (MPLA) is an analog of the lipid A moiety. It is regarded as a detoxified derivative of the lipopolysaccharide (LPS).

Ações bioquímicas/fisiológicas

Monophosphoryl lipid A (MPLA) is a natural agonist for the toll-like receptor-4 (TLR4). It is useful as an adjuvant in immunization. MPLA is a safe prophylactic agent and has immunotherapeutic applications. It induces tumor necrosis factor and interleukin (IL)-1β, however not as efficient as lipopolysaccharide (LPS). MPLA improves immune response during bacterial sepsis infection.

Embalagem

2 mL Amber Glass Crimp Cap Vial (699851P-1mg)

2 mL Amber Glass Crimp Cap Vial (699851P-5mg)

Outras notas

For R&D use only. Not for drug, household, or other uses.

Informações legais

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Informações de segurança

• Código de classe de armazenamento: 11 - Combustible Solids
• Classe de risco de água (WGK): WGK 3
• Ponto de fulgor (°F): No data available
• Ponto de fulgor (°C): No data available